He, Jian <br/><br/>
Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells.  [electronic resource] 

 -  Anti-cancer drugs  01 2019 
 - 19-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000684  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aurora Kinase B--antagonists & inhibitors<br/>Case-Control Studies<br/>Cell Line, Tumor<br/>Dose-Response Relationship, Drug<br/>Glucose--metabolism<br/>Glucose Transporter Type 1--metabolism<br/>Humans<br/>Isoenzymes--metabolism<br/>L-Lactate Dehydrogenase--metabolism<br/>Organophosphates--pharmacology<br/>Promoter Regions, Genetic<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-myc--genetics<br/>Quinazolines--pharmacology<br/>Ribosomal Proteins--metabolism<br/>Stomach Neoplasms--drug therapy